Contractor, Global Medical Strategy and Studies jobs in United States
cer-icon
Apply on Employer Site
company-logo

Syndax Pharmaceuticals · 9 hours ago

Contractor, Global Medical Strategy and Studies

Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Global Medical Affairs Strategy and Studies contractor will support the Global Medical Strategy team, gaining hands-on experience in how Medical Affairs executes Investigator Sponsored Trials (ISTs) and drives scientific and strategic planning at Syndax.

BiotechnologyClinical TrialsHealth CarePharmaceutical

Responsibilities

Assist in creating internal strategic deliverables, such as slide decks, scientific background materials, and planning documents, including contributing to components of Global Medical strategic plans
Serve as liaison between Syndax and external stakeholders, such as IST investigators and site staff, to foster collaboration and ensure high-quality execution
Manage protocol reviews, timelines, budgets, site and vendor relationships for assigned studies
Monitor study progress, provide regular updates to leadership, and proactively address operational challenges to ensure timely study activation and execution
Maintain tracking for IST metrics (e.g., contracts, activation timelines, enrollment, projected publication timelines, etc.)
Participate in team meetings and provide regular project updates, contributing to discussions on progress, insights, and strategic implications

Qualification

Doctor of Pharmacy (PharmD)Medical AffairsOncologyData visualization toolsAnalytical skillsClinical research interestWritten communicationVerbal communicationAttention to detailTeam collaboration

Required

Doctor of Pharmacy (PharmD) degree
Strong interest in Medical Affairs, oncology, and drug development
Ability to interpret and summarize scientific literature with clarity and accuracy
Analytical skillset with experience using tools such as Excel, Power BI, or other data visualization platforms
Excellent written and verbal communication skills
Ability to work independently and as part of a collaborative team
High attention to detail and commitment to quality work
Genuine interest in clinical research and drug development
Proven verbal and written communication skills; enjoys interacting with others regularly
Able to prioritize tasks and work independently
Willingness to travel (approx. 15%)

Company

Syndax Pharmaceuticals

twittertwittertwitter
company-logo
Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.

Funding

Current Stage
Public Company
Total Funding
$1.1B
Key Investors
Royalty Pharma
2024-11-04Post Ipo Debt· $350M
2023-12-14Post Ipo Equity· $230M
2022-12-06Post Ipo Equity· $150M

Leadership Team

leader-logo
Michael Metzger
Chief Executive Officer and Director
linkedin
leader-logo
Keith A. Goldan
Chief Financial Officer
linkedin
Company data provided by crunchbase